DMII earnings: real EPS beat/miss history, P/E 0.60. Updated 2026-07-23.
Drugs Made In America Acquisition II (DMII) Research Hub
Drugs Made In America Acquisition II (DMII) trades on NASDAQ, US in the Financial Services (Shell Companies) sector. As of 2026-09-11, shares last closed at 10.163 USD (+0.03%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 0.60, market cap 0.53B. This hub links to the full technical, earnings and options research available for DMII.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Financial Services (Shell Companies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.163 USD (+0.03%) |
| 52-week range | 10.05 USD – 10.21 USD |
| Trend regime | Range |
| 14-day RSI | 67.3 (Bullish) |
| Trailing P/E | 0.60 |
| Market cap | 0.53B |
| Dividend yield | 0.00% |
Available research for DMII
Covered Call on DMII: how it works, illustrative setup around the real 10.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DMII: how it works, illustrative setup around the real 10.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DMII: how it works, illustrative setup around the real 10.16 USD price, max profit/loss, breakeven and when to use it. Educational.
DMII technical analysis: range, last 10.163 USD, RSI 67.3, 52w range 10.05 USD–10.21 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DMII in?
Drugs Made In America Acquisition II (DMII) is classified under Financial Services (Shell Companies), listed on NASDAQ, US.
Is DMII in an uptrend or downtrend?
As of 2026-09-11, DMII is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DMII's trailing P/E ratio?
DMII's trailing P/E is 0.60, with a market cap of 0.53B. See the earnings research page for full valuation detail.